Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lack of evidence for associations between plasma platelet-activating factor acetylhydrolase deficiency and schizophrenia.

Psychiatry research - 31 Jan 2002

Ohtsuki Tsuyuka, Watanabe Hideki, Toru Michio, Arinami Tadao

Abstract excerpt

Platelet-activating factor (PAF) is a potent phospholipid mediator that plays various roles in neuronal function and brain development. It is involved in NMDA receptor function. Release and degradation of PAF is controlled by intracellular and plasma PAF-acetylhydrolase (PAFAH). The plasma PAFAH gene (PLA2G7) is located on chromosome 6p. A previous study showed weak associations of the Ile198Thr and Val379Ala...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 1-Alkyl-2-acetylglycerophosphocholine Esterase
Share to Acetyltransferases

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Case-Control Studies

Share to Gene Frequency

Share to Phospholipases A

Share to Point Mutation

Share to Receptors, N-Methyl-D-Aspartate

Share to Schizophrenia

Source

Identifiers

PMID: 11850055
DOI: 10.1016/s0165-1781(01)00353-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lack of evidence for associations between plasma platelet-activating factor acetylhydrolase deficiency and schizophrenia.PMID 11850055Read ↗

Plasma platelet-activating factor acetylhydrolase deficiency in Japanese patients with asthma.Semantic proximity Read ↗

Platelet-activating factor acetylhydrolases in health and disease.Semantic proximity Read ↗

Genetic deficiency of plasma lipoprotein-associated phospholipase A2 (PLA2G7 V297F null mutation) and risk of Alzheimer's disease in Japan.Semantic proximity Read ↗

A mutation in plasma platelet-activating factor acetylhydrolase (Val279-->Phe) is a genetic risk factor for stroke.Semantic proximity Read ↗

Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase.Semantic proximity Read ↗

Lack of association between schizophrenia and the phospholipase-A(2) genes cPLA2 and sPLA2.Semantic proximity Read ↗

Systematic screening of the LDL-PLA2 gene for polymorphic variants and case-control analysis in schizophrenia.Semantic proximity Read ↗

Allelic association analysis of phospholipase A2 genes with schizophrenia.Semantic proximity Read ↗

Lack of association between schizophrenia and a polymorphism close to the cytosolic phospholipase A2 gene.Semantic proximity Read ↗

Polymorphisms in PLA2G6 and PLA2G4C genes for calcium-independent phospholipase A2 do not contribute to attenuated niacin skin flush response in schizophrenia patients.Semantic proximity Read ↗

The Ile198Thr and Ala379Val variants of plasmatic PAF-acetylhydrolase impair catalytical activities and are associated with atopy and asthma.Semantic proximity Read ↗

Platelet-activating factor acetylhydrolase gene polymorphism and its activity in Japanese patients with multiple sclerosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.